SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: DaiS who wrote (18379)1/29/1999 9:01:00 PM
From: alan laValley  Read Replies (2) of 23519
 
DaiS: First, thanks for your response. As I think about this situation more, I realize the precarious position Wilson has placed this company in. Without a sales force, we are dead in the water (not news right) Perhaps this was a motivating factor in Vivus trying to create a sales force, not just to sell Muse, but for the independence from other company's. Now we are weak in the uSA and delays in Europe. No longer are we in control of our own destiny, but rather completely dependent on the will of others.
But......are we? Wilson is trying to buy some time. Time to develop Alibra (a replacement for Muse) hopefully without ties to present international contracts. Time for Viaga to "settle in" and deal with the health issues as well as gradually move users to muse. He has Vivus on a austerity budget while waiting with enough cash to survive.
Just trying to make some logic of this situation...Would like comments
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext